Healthtech Startups

ReferralPoint develops an AI-powered referral management platform for healthcare organizations to optimize the referral process across health systems, medical groups, and payers. The platform reduces referral costs and leakage through intelligent provider matching and automated coordination workflows.

2 investors

ReferWell provides referral management and appointment scheduling technology combined with expert care navigators to help health plans and providers close care gaps and get members to their appointments. It serves health plans, ACOs, provider organizations, and FQHCs across the US healthcare market.

2 investors

ReGelTec develops injectable hydrogel technology for the repair of the nucleus pulposus of the intervertebral disc, targeting interventional pain management and spine care. The company is a medical device (MedTech) startup combining academic research in crosslinked polymers with experienced medical device executives.

2 investors

Regulus Therapeutics was a San Diego-based clinical-stage biopharmaceutical company developing oligonucleotide drugs that inhibit disease-causing microRNAs. Its lead program, farabursen, targeted miR-17 for treating autosomal dominant polycystic kidney disease.

2 investors

Relode is a healthcare staffing and recruitment company that places healthcare professionals with medical facilities. It works as a recruitment partner to help healthcare organizations fill open positions and match candidates to roles.

2 investors

Relu offers AI-powered segmentation and registration software for CBCT scans, digital impressions, and facial scans used in dental and oral surgery workflows. The company provides APIs and SDKs that enable dental software developers to automate implant planning, orthodontics, and surgical applications.

2 investors

Rematiq builds an AI-driven platform for product and regulatory compliance in life sciences, connecting requirements, regulations, evidence and submissions in one system and automating traceability, compliance checks and document generation. Each deployment includes an embedded domain team that handles integrations (e.g. Veeva, Polarion, SharePoint), validation and workflow rollout inside a customer's quality management system.

2 investors

Remedial Health offers a pharmacy benefit solution for health insurers and HMOs, handling pharmaceutical purchasing, medication distribution to plan members, formulary management, and a virtual doctor service with claims visibility. It targets insurers managing members with long-term medication needs to reduce avoidable doctor visits and hospital admissions.

2 investors

Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein. Its work targets diseases such as osteoarthritis, arthritis, and diabetes-related metabolic conditions.

2 investors

Remedy Health Media is a health communications company that combines lived patient experience with clinical evidence to create media, apps, and influencer platforms for people with chronic, serious, and rare conditions. The company operates through six brands offering community apps, healthcare provider influencer networks, and content production services.

2 investors

Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke. It focuses on treatments for serious neurological conditions.

2 investors

Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer. Its lead clinical candidate, RPT1G, is a hyperbolic inhibitor designed to reduce NAMPT activity while avoiding the toxicity that has limited earlier attempts.

2 investors

Remy provides automation software that handles insurance administration tasks for medical practices, including benefit verification calls and claims status inquiries.

2 investors

remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients with age-related neurodegenerative diseases such as Alzheimer's and Huntington's, and runs a discovery program targeting mitochondrial dysfunction in ALS. It also operates a contract research organization (CRO) that uses proprietary mouse models to help pharmaceutical companies in the US, Europe and Japan assess experimental neurodegenerative disease treatments.

2 investors

Renalis develops prescription digital therapeutics (PDTs), software applications that deliver evidence-based therapeutic interventions to patients under a clinician's care to prevent or treat medical disorders. The products are developed like pharmaceuticals, undergoing clinical trials and FDA clearance, and are available only by clinician prescription.

2 investors

Renalyse is developing a point-of-care device for measuring creatinine and potassium in blood, intended as part of a platform for remote renal monitoring. It targets chronic kidney disease (CKD) management by connecting patients with healthcare professionals to provide real-time patient data to doctors.

2 investors

Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD). Its pipeline targets the underlying biology of ADPKD across a range of mutations with the goal of halting and reversing disease progression.

2 investors

Repertoire's Decode platform focuses on mapping the immune synapse — the interactions between T cell receptors, epitopes, and HLA molecules — to support the development of medicines targeting cancer and other diseases. It operates in immunology-based drug discovery and therapeutics.

2 investors

Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.

2 investors

Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.

2 investors

Resilience Care builds digital tools that capture and analyze patient data in real time to support personalized medicine and clinical research, initially in oncology and expanding to psychiatry and gastroenterology. The company works with clinicians, researchers, and patients to improve care pathways.

2 investors

Resilient Biotics uses microbiome genomics and data science to discover and develop non-antibiotic, precision microbial therapeutics derived from commensal microbial communities, aimed at preventing respiratory infectious diseases.

2 investors

Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.

2 investors

Resolyst is an AI-enabled platform for specialty medical care, providing continuous, multidisciplinary monitoring and support for patients with chronic and complex conditions such as psoriatic arthritis. It connects patients with specialist-led care teams and international expert panels of clinicians for ongoing oversight and second opinions.

2 investors